Journal profile · DERMATOLOGY-NURSING
Journal of Tissue Viability
ISSN 0965-206X · eISSN 1876-4746 · Tissue Viability Society · ENGLAND
Journal of Tissue Viability: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.47; hybrid open access; APC about USD 2,790; median 131 days to acceptance (104 articles, last 24 months); community-reported acceptance: easy; 119 articles in 2025; indexed in SCIE, SSCI and Scopus.
Scope
Aims, scope and focus
Journal of Tissue Viability is published by Tissue Viability Society and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pressure Ulcer Prevention and Management, Wound Healing and Treatments and Diabetic Foot Ulcer Assessment and Management, together about 54.3% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Tissue Viability is the official publication of the Society of Tissue Viability and is a quarterly journal concerned with all aspects of the occurrence and treatment of wounds, ulcers and pressure sores including patient care, pain, nutrition, wound healing, research, prevention, mobility, social problems and management.The Journal particularly encourages papers covering skin and skin wounds, but will consider articles that discuss injury in any tissue. Articles that stress the multi-professional nature of tissue viability are especially welcome. We seek to encourage new authors as well as well-established contributors to the field - one aim of the journal is to enable all participants in tissue viability to share information with colleagues.
From the journal's Aims & Scope
Research area (LetPub): DERMATOLOGY-NURSING
Editor-in-chief D. PattonPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 14, Ireland 10, Australia 7, United States 4, Switzerland 2 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pressure Ulcer Prevention and ManagementHealth Professions26.2%
- Wound Healing and TreatmentsMedicine18.1%
- Diabetic Foot Ulcer Assessment and ManagementMedicine9.9%
- Diagnosis and Treatment of Venous DiseasesMedicine6.9%
- Surgical site infection preventionMedicine4.8%
- Human auditory perception and evaluationEngineering3.5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.4%
- Stoma care and complicationsMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Nursing | Zone 2 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 2 |
| Minor | Nursing | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 2 |
| Minor | Nursing | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIESSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.47LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore (publisher)
- 4.8Publisher website ·
- SJR 2026-06
- 0.73LetPub ·
- SNIP 2026-06
- 1.15LetPub ·
- h-index
- 27LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 551OpenAlex ·
- 2-year mean citedness
- 3.55OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 54.17%LetPub ·
Volume
- Articles per year
- 104LetPub ·
Articles by year OpenAlex count · 1,902 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 71 | 24 |
| 2025 | 119 | 118 | 372 |
| 2024 | 150 | 71 | 813 |
| 2023 | 94 | 45 | 876 |
| 2022 | 106 | 43 | 1,360 |
| 2021 | 106 | 42 | 1,513 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
131 daysMedian, submission to acceptance · P25–P75 84 days – 202 days
- Acceptance to online
- median 1 days (104 articles)
- Submission to online
- median 134 days
- Sample
- 104 articles with submission and acceptance dates (269 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to acceptance
- 143 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,790 / EUR 2,610 / GBP 2,231 / JPY 346,040 | — | — | |
| Publisher website | USD 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10, with length limits
- basic research studiesBasic research studies (1500-3000 words)Length not stated
- case reportClinical studies (1500-3000 words)Basic research studies (1500-3000 words)Case reports (500-1500 words)Reports of either an individual or a series of case histo…main text ≤ 1,500 words
- case reportsCase reports (500-1500 words)Length not stated
- clinical studiesClinical studies (1500-3000 words)Length not stated
- editorialClinical studies (1500-3000 words)Basic research studies (1500-3000 words)Case reports (500-1500 words)Reports of either an individual or a series of case histo…Length not stated
- guest editorialsGuest editorialsLength not stated
- letterClinical studies (1500-3000 words)Basic research studies (1500-3000 words)Case reports (500-1500 words)Reports of either an individual or a series of case histo…Length not stated
- letters to the editorClinical studies (1500-3000 words)Basic research studies (1500-3000 words)Case reports (500-1500 words)Reports of either an individual or a series of case histo…Length not stated
- reviewClinical studies (1500-3000 words)Basic research studies (1500-3000 words)Case reports (500-1500 words)Reports of either an individual or a series of case histo…main text ≤ 4,000 words
- systematic reviewClinical studies (1500-3000 words)Basic research studies (1500-3000 words)Case reports (500-1500 words)Reports of either an individual or a series of case histo…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Tissue Viability Society
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 0965-206X
- Electronic ISSN
- 1876-4746
- Society / sponsor
- Society of Tissue Viability
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Tissue Viability
What CAS zone is Journal of Tissue Viability in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Tissue Viability is in Zone 3 of Medicine, and in Zone 2 of the minor category Nursing / Dermatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Tissue Viability?
The latest impact factor listed by LetPub is 2.47; CiteScore 4.8, h-index 60.
How long does peer review take at Journal of Tissue Viability?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 131 days (interquartile range 84–202 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Tissue Viability based?
Of the 44 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (14), Ireland (10) and Australia (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Tissue Viability?
According to LetPub and DOAJ records, Journal of Tissue Viability is indexed in SCIE, SSCI and Scopus.
Is Journal of Tissue Viability open access, and what is the APC?
Journal of Tissue Viability is a hybrid journal. For open-access publication: APC about USD 2,790.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .